Conmed (CNMD) Operating Margin Growth (1y) (2011 - 2026)

Conmed (CNMD) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Abbott Laboratories 180.89 Bn 173.59 Bn 6.27 Bn -430.00
2 Stryker 127.82 Bn 124.94 Bn 3.81 Bn 128.00
3 Medtronic 107.49 Bn 98.27 Bn 6.41 Bn 301.00
4 Boston Scientific 67.24 Bn 65.78 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 48.02 Bn 44.34 Bn 1.29 Bn 102.00
6 Dexcom 28.25 Bn 27.14 Bn 750.30 Mn 851.00
7 GE HealthCare Technologies 28.17 Bn 25.89 Bn 1.98 Bn -313.00
8 Smith & Nephew 26.72 Bn 26.14 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn 241.00
10 Conmed 1.32 Bn 1.29 Bn 183.45 Mn 305.00

Historic Data

Download Data
DateValue
Mar 31, 2026 305.00
Dec 31, 2025 -536.00
Sep 30, 2025 -1,723.00
Jun 30, 2025 -304.00
Mar 31, 2025 -624.00
Dec 31, 2024 -17.00
Sep 30, 2024 1,080.00
Jun 30, 2024 555.00
Mar 31, 2024 691.00
Dec 31, 2023 1,578.00
Sep 30, 2023 113.00
Jun 30, 2023 -19.00
Mar 31, 2023 -496.00
Dec 31, 2022 -1,402.00
Sep 30, 2022 -192.00
Jun 30, 2022 -125.00
Mar 31, 2022 63.00
Dec 31, 2021 381.00
Sep 30, 2021 -162.00
Jun 30, 2021 2,354.00